Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Up 9.3% in November

Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Free Report) was the target of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 6,550,000 shares, a growth of 9.3% from the October 31st total of 5,990,000 shares. Based on an average trading volume of 1,600,000 shares, the short-interest ratio is currently 4.1 days.

Analyst Ratings Changes

Several brokerages recently weighed in on ACHC. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, November 22nd. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, October 1st. Barclays cut their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. Royal Bank of Canada decreased their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday, November 18th. Finally, KeyCorp assumed coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $79.67.

View Our Latest Research Report on Acadia Healthcare

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $40.63 on Monday. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The company’s 50-day moving average price is $50.46 and its two-hundred day moving average price is $63.52. The stock has a market cap of $3.77 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.80 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.91 EPS. As a group, sell-side analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently modified their holdings of the stock. Point72 Asset Management L.P. lifted its holdings in shares of Acadia Healthcare by 266.0% during the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock valued at $153,339,000 after purchasing an additional 1,650,040 shares during the last quarter. Wellington Management Group LLP raised its holdings in Acadia Healthcare by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after buying an additional 1,266,384 shares during the period. Millennium Management LLC lifted its stake in Acadia Healthcare by 3,067.8% during the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after buying an additional 1,055,894 shares in the last quarter. Holocene Advisors LP boosted its holdings in shares of Acadia Healthcare by 201.5% in the third quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock worth $61,667,000 after buying an additional 649,997 shares during the period. Finally, William Blair Investment Management LLC increased its position in shares of Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after acquiring an additional 604,070 shares in the last quarter.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.